MoneyWorks4Me

Net sales declined -5.96%  to  Rs. 5430.90 million from Rs. 5775.40 millions.The Company's Net profit for the September 2024 quarter have declined marginally to Rs. 303.90  millions as against Rs. 345.80 millions reported during the corresponding quarter ended.A decline of 599.20 millions was observed in the OP in the quarter ended September 2024 from 661.60 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 5430.90 5775.40 -5.96 10360.50 11691.70 -11.39 22669.10 24979.70 -9.25
Other Income 3.80 7.40 -48.65 4.90 13.90 -64.75 41.80 22.30 87.44
PBIDT 599.20 661.60 -9.43 1142.50 1387.20 -17.64 2703.10 2846.30 -5.03
Interest 71.70 75.50 -5.03 146.30 153.20 -4.50 301.60 325.30 -7.29
PBDT 527.50 586.10 -10.00 996.20 1234.00 -19.27 2401.50 2521.00 -4.74
Depreciation 118.60 117.80 0.68 235.70 235.30 0.17 476.70 472.90 0.80
PBT 408.90 468.30 -12.68 760.50 998.70 -23.85 1924.80 2048.10 -6.02
TAX 105.00 122.50 -14.29 187.50 257.50 -27.18 506.00 520.00 -2.69
Deferred Tax 20.00 12.50 60.00 25.00 20.00 25.00 10.00 -12.50 -180.00
PAT 303.90 345.80 -12.12 573.00 741.20 -22.69 1418.80 1528.10 -7.15
Equity 912.70 919.40 -0.73 919.40 926.00 -0.71 919.40 926.00 -0.71
PBIDTM(%) 11.03 11.46 -3.69 11.03 11.86 -7.06 11.92 11.39 4.65
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..